A Randomized, Double-Blind, Placebo-Controlled Phase 2 study to evaluate the effect of PBT2 (once daily for 52 weeks) on Abeta deposition in the brain of patients with Alzheimer's Disease

Research Categorization
Researcher and Organization
Principal Investigator
Principal Investigator First Name
Principal Investigator Last Name
Awardee Organization
Contact PI Country
Project Detail
Funding Opportunity Announcement
FY Overall Cost
Funding Organization
Agency/Funding Organization
Funding Organization Country